Deere & Company’s GSK GSK Stock Holding History

Deere & Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-16,062	Closed	-$866K	–	312
2016 Q3	$866K	Hold	16,062	–	–	0.05%	445
2016 Q2	$870K	Sell	16,062 -2,000	-11%	-$105K	0.05%	415
2016 Q1	$915K	Hold	18,062	–	–	0.05%	401
2015 Q4	$911K	Sell	18,062 -2,441	-12%	-$124K	0.05%	349
2015 Q3	$985K	Hold	20,503	–	–	0.06%	316
2015 Q2	$1.07M	Buy	20,503 +2,437	+13%	+$137K	0.06%	345
2015 Q1	$1.04M	Hold	18,066	–	–	0.06%	332
2014 Q4	$965K	Hold	18,066	–	–	0.05%	381
2014 Q3	$1.04M	Buy	18,066 +2,967	+20%	+$182K	0.06%	360
2014 Q2	$1.01M	Hold	15,099	–	–	0.06%	371
2014 Q1	$1.01M	Hold	15,099	–	–	0.06%	366
2013 Q4	$1.01M	Buy	15,099 +1,282	+9%	+$83.1K	0.05%	391
2013 Q3	$866K	Buy	13,817 +1,152	+9%	+$74.2K	0.05%	412
2013 Q2	$791K	Buy	+12,665	New	+$804K	0.05%	397

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deere & Company's GSK Position: Q4 2016 in Review

Deere & Company sold out of GSK (GSK) in Q4 2016, closing a stake of 16,062 shares — an estimated $866K sold.

Deere & Company first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $1.07M in Q2 2015. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

Deere & Company reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
Deere & Company sold 16,062 GSK shares in Q4 2016, an estimated $866K.
Deere & Company first reported a position in GSK in Q2 2013 and held it in 14 quarters.
Deere & Company's GSK position peaked at $1.07M in Q2 2015.
762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.